About Talking Medicines
The journey of Talking Medicines began with a shared vision: to improve Patient outcomes and empower decision-makers across healthcare and Life Sciences. From day one, our mission has been clear, to blend innovation, quality, community, and transparency in everything we do.
Talking Medicines is Data Science for Life Sciences, applying proprietary, domain-trained technology to turn real-world data into intelligence that drives meaningful ROI. Our sector-specific platforms, DrugVoice and PeopleVoice, use Advanced Data Science and AI to structure this data, enabling organizations to make confident, data-driven decisions.
Founders: Elizabeth Fairley, Jo Halliday, Scott Crae
About TMLabs
Innovating Predictive Intelligence for Life Sciences.
TMLabs is the in-house research and development hub of Talking Medicines, created to push the boundaries of Advanced Data Science and AI including Natural Language Processing, Machine Learning, and predictive intelligence. Guided by our mission to close the intelligence gap in Life Sciences, TMLabs develops proprietary, domain-trained technologies that turn unstructured conversations into actionable insights.
By combining cutting-edge science with deep healthcare expertise, TMLabs ensures our solutions reflect the complexity of real-life data while delivering measurable impact.
Turn Complex Data Into Clear Intelligence That Drives Smarter Decisions
Message Alignment
Measure how key messages resonate and track changes over time, and link findings to ROI
Persona Development
Identify patterns, key characteristics, and distinctions within groups or populations of authors to inform strategy and uncover meaningful trends
